Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.7665
+0.0215 (2.89%)
May 8, 2026, 4:00 PM EDT - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $27.93 million as of May 11, 2026. Its market cap has decreased by -23.27% in one year.
Market Cap
27.93M
Enterprise Value
25.67M
1-Year Change
-23.27%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $27.93M, a decrease of -70.54%. That is a compound annual growth rate of -15.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 28.10M | -17.35% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 30.30M |
| BriaCell Therapeutics | 29.77M |
| Quantum BioPharma | 29.75M |
| Tempest Therapeutics | 28.54M |
| Lisata Therapeutics | 28.45M |
| Neuphoria Therapeutics | 28.36M |
| Kyntra Bio | 28.13M |
| Barinthus Biotherapeutics | 27.37M |